Filling the need for trusted information on national health issues…

AP/News-Observer Examines State Of Vaccine Research

The Associated Press/News-Observer examines revitalized vaccine research, including for such conditions as malaria, TB and HIV. “Vaccines are no longer a sleepy, low-profit niche in a booming drug industry. Today, they’re starting to give ailing pharmaceutical makers a shot in the arm,” according to the article. The AP/News-Observer looks at specific company focal points and vaccine sales forecasts as well as how “[t]he lure of big profits, advances in technology and growing government support has been drawing in new companies, from nascent biotechs to Johnson & Johnson” to vaccines.

Emilio Emini, Pfizer’s head of vaccine research, said, “Even if a small portion of everything that’s going on now is successful in the next 10 years, you put that together with the last 10 years [and] it’s going to be characterized as a golden era.”

According to AP/News-Observer, “many companies are partnering with promising biotechs, the World Health Organization and global charities, or setting up deals with local drugmakers abroad, to inexpensively manufacture vaccines in developing and middle-tier countries that increasingly want them to prevent much-higher health care costs” (Johnson, 11/20).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.